192 related articles for article (PubMed ID: 23908346)
21. Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer.
Lee HY; Lee HJ; Kim YT; Kang CH; Jang BG; Chung DH; Goo JM; Park CM; Lee CH; Kang KW
J Thorac Oncol; 2010 Apr; 5(4):497-503. PubMed ID: 20195167
[TBL] [Abstract][Full Text] [Related]
22. Initial partial response and stable disease according to RECIST indicate similar survival for chemotherapeutical patients with advanced non-small cell lung cancer.
He L; Teng Y; Jin B; Zhao M; Yu P; Hu X; Zhang J; Li S; Gao Y; Liu Y
BMC Cancer; 2010 Dec; 10():681. PubMed ID: 21156055
[TBL] [Abstract][Full Text] [Related]
23. Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?
Lind JS; Meijerink MR; Dingemans AM; van Kuijk C; Ollers MC; de Ruysscher D; Postmus PE; Smit EF
Eur Radiol; 2010 Dec; 20(12):2890-8. PubMed ID: 20625738
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France.
Chouaid C; Bensimon L; Clay E; Millier A; Levy-Bachelot L; Huang M; Levy P
Lung Cancer; 2019 Jan; 127():44-52. PubMed ID: 30642550
[TBL] [Abstract][Full Text] [Related]
25. Radiologic Pseudoprogression during Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer.
Katz SI; Hammer M; Bagley SJ; Aggarwal C; Bauml JM; Thompson JC; Nachiappan AC; Simone CB; Langer CJ
J Thorac Oncol; 2018 Jul; 13(7):978-986. PubMed ID: 29738824
[TBL] [Abstract][Full Text] [Related]
26. The predictive value of
Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
[TBL] [Abstract][Full Text] [Related]
27. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience.
Bellomi M; Petralia G; Sonzogni A; Zampino MG; Rocca A
Radiology; 2007 Aug; 244(2):486-93. PubMed ID: 17641369
[TBL] [Abstract][Full Text] [Related]
28. Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy.
Gandhi D; Chepeha DB; Miller T; Carlos RC; Bradford CR; Karamchandani R; Worden F; Eisbruch A; Teknos TN; Wolf GT; Mukherji SK
AJNR Am J Neuroradiol; 2006 Jan; 27(1):101-6. PubMed ID: 16418366
[TBL] [Abstract][Full Text] [Related]
29. Role of CT perfusion imaging in patients with variously differentiated gastric adenocarcinoma.
Sun ZQ; Cheng XF; Ge YX; Chen L; Yue JG; Jin LF; Xie ZH; Zhang HD; Xuan YH
J Xray Sci Technol; 2015; 23(6):737-44. PubMed ID: 26756409
[TBL] [Abstract][Full Text] [Related]
30. Predicting tumor hypoxia in non-small cell lung cancer by combining CT, FDG PET and dynamic contrast-enhanced CT.
Even AJG; Reymen B; La Fontaine MD; Das M; Jochems A; Mottaghy FM; Belderbos JSA; De Ruysscher D; Lambin P; van Elmpt W
Acta Oncol; 2017 Nov; 56(11):1591-1596. PubMed ID: 28840770
[TBL] [Abstract][Full Text] [Related]
31. Imaging Tumor Response and Tumoral Heterogeneity in Non-Small Cell Lung Cancer Treated With Antiangiogenic Therapy: Comparison of the Prognostic Ability of RECIST 1.1, an Alternate Method (Crabb), and Image Heterogeneity Analysis.
Yip C; Tacelli N; Remy-Jardin M; Scherpereel A; Cortot A; Lafitte JJ; Wallyn F; Remy J; Bassett P; Siddique M; Cook GJ; Landau DB; Goh V
J Thorac Imaging; 2015 Sep; 30(5):300-7. PubMed ID: 26164165
[TBL] [Abstract][Full Text] [Related]
32. Assessing response to treatment in non--small-cell lung cancer: role of tumor volume evaluated by computed tomography.
Knollmann FD; Kumthekar R; Fetzer D; Socinski MA
Clin Lung Cancer; 2014 Mar; 15(2):103-9. PubMed ID: 24361250
[TBL] [Abstract][Full Text] [Related]
33. The value of perfusion CT in predicting the short-term response to synchronous radiochemotherapy for cervical squamous cancer.
Li XS; Fan HX; Zhu HX; Song YL; Zhou CW
Eur Radiol; 2012 Mar; 22(3):617-24. PubMed ID: 21960157
[TBL] [Abstract][Full Text] [Related]
34. Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression.
Ma SH; Le HB; Jia BH; Wang ZX; Xiao ZW; Cheng XL; Mei W; Wu M; Hu ZG; Li YG
BMC Cancer; 2008 Jun; 8():186. PubMed ID: 18590539
[TBL] [Abstract][Full Text] [Related]
35. Human Recombinant Endostatin Combined with Cisplatin Based Doublets in Treating Patients with Advanced NSCLC and Evaluation by CT Perfusion Imaging.
Zhang FL; Gao EY; Shu RB; Wang H; Zhang Y; Sun P; Li M; Tang W; Jiang BQ; Chen SQ; Cui FB
Asian Pac J Cancer Prev; 2015; 16(15):6765-8. PubMed ID: 26434908
[TBL] [Abstract][Full Text] [Related]
36. Assessment of bronchial and pulmonary blood supply in non-small cell lung cancer subtypes using computed tomography perfusion.
Nguyen-Kim TD; Frauenfelder T; Strobel K; Veit-Haibach P; Huellner MW
Invest Radiol; 2015 Mar; 50(3):179-86. PubMed ID: 25500892
[TBL] [Abstract][Full Text] [Related]
37. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):537-44. PubMed ID: 9336129
[TBL] [Abstract][Full Text] [Related]
38. Impact of different image reconstructions on PET quantification in non-small cell lung cancer: a comparison of adenocarcinoma and squamous cell carcinoma.
Messerli M; Kotasidis F; Burger IA; Ferraro DA; Muehlematter UJ; Weyermann C; Kenkel D; von Schulthess GK; Kaufmann PA; Huellner MW
Br J Radiol; 2019 Apr; 92(1096):20180792. PubMed ID: 30673302
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of preoperative CT enhancement rate and CT perfusion parameters in colorectal cancer.
Li ZM; Zhou W; Feng L; Zhang HY; Chen WB
BMC Gastroenterol; 2024 May; 24(1):176. PubMed ID: 38773485
[TBL] [Abstract][Full Text] [Related]
40. CT Volumetry and Basic Texture Analysis as Surrogate Markers in Advanced Non-small-cell Lung Cancer.
Owen B; Gandara D; Kelly K; Moore E; Shelton D; Knollmann F
Clin Lung Cancer; 2020 May; 21(3):225-231. PubMed ID: 31699509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
